Price T Rowe Associates Inc Verastem, Inc. Transaction History

Price T Rowe Associates Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.02 - $1.83 $15,421 - $27,667	-15,119 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.06 - $2.1 $3,922 - $7,770	3,700 Added 32.4%	15,119 $21,000
Q4 2021 Feb 14, 2022	SELL	$2.05 - $3.2 $5,944 - $9,280	-2,900 Reduced 20.25%	11,419 $23,000
Q3 2021 Nov 15, 2021	BUY	$2.54 - $4.07 $1,270 - $2,035	500 Added 3.62%	14,319 $44,000
Q2 2021 Aug 16, 2021	BUY	$2.57 - $4.85 $5,183 - $9,782	2,017 Added 17.09%	13,819 $56,000
Q1 2021 May 17, 2021	BUY	$1.9 - $2.82 $41 - $62	22 Added 0.19%	11,802 $29,000
Q4 2020 Feb 16, 2021	BUY	$1.15 - $2.4 $13,546 - $28,272	11,780 New	11,780 $25,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $840M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.